Sort by
Refine Your Search
-
Employer
-
Field
-
the information encoded in our genome to better diagnose, treat, predict and prevent disease. From the individual patient with rare disease, to the many thousands affected by complex, widespread illness, we
-
. The position will provide technical and research knowledge in the field of implementation science, contributing to a range of projects conducted within the Implementation to Impact program, School of Population
-
) Sydney, in partnership with ANSTO (Australia), Imperial College London (UK), and Tokamak Energy (UK), is launching a groundbreaking research program focused on developing new materials for compact tokamak
-
Premier’s Science Fellowship Program, the Population Biology and Genomics Group is a new and rapidly growing research group in the School of Molecular and Life Sciences at Curtin University. To find out more
-
on Parkinson’s Disease-associated chronic constipation. This prevalent condition negatively affects the quality of life for most individuals with Parkinson’s Disease, and your work will directly contribute to
-
, contributing to high-impact research on ageing and demographic transitions, particularly in emerging Asian economies such as China, Vietnam, Thailand, and Indonesia. This role involves independent and
-
shielding, radiation damage, particle transport. Computational skills allowing to compose or modify comprehensive simulation open-source codes. Experience in data analysis and simulations of complex and
-
. What You'll Be Doing Collecting data in flood-affected communities through surveys, interviews, and focus groups Conducting both qualitative and quantitative analysis to assess social impacts
-
contributing to work that matters. What You’ll Be Doing Collecting data in flood-affected communities through surveys, interviews, and focus groups Conducting both qualitative and quantitative analysis to assess
-
Doctoral Scientist position. This position will report to Professor Jose Polo, Lead of the Cancer Epigenetics Program at the South Australian Immunogenomics Cancer Institute (SAiGENCI) and the Inaugural